Barański W, Janowski T, Raś M, Zduńczyk S, Opsomer G, Dewulf J, de Kruif A (2008) Incidence of reproduction disorders and fertility parameters in dairy herds under the herd health program. Med Weter 64: 807-811.
Bogucki M, Sawa A, Neja W (2007) Differences in fertility parameters of dairy cows due to increasing lactation yield. Acta Sci Pol Zootech 6: 3-10.
Borkowska D, Piatek D, Januś E, Mucha J (2012) Fertility indices of cows in a high-yielding herd. Rocz Nauk PTZ 8: 21-29.
Butler WR (2003) Energy balance relationships with follicular development, ovulation and fertility in postpartum dairy cows. Livest Prod Sci 83: 211-218.
de Kruif A, Opsomer G (2004) Integrated dairy herd health management as the basis for prevention. Vlaams Diergeneeskd Tijdschr 73: 44-52.
de Kruif A, Leroy J, Opsomer G (2008) Reproductive performance in high producing dairy cows: practical implications. Tierarztl Prax 36 (Suppl 1): 29-33.
Derks M, van Werven T, Hogeveen H, Kremer WD (2013) Veterinary herd health management programs on dairy farms in the Netherlands: use, execution, and relations to farmer characteristics. J Dairy Sci 96: 1623-1637.
Dobson H, Smith R, Royal M, Knight CH, Sheldon I (2007) The high-producing dairy cow and its reproductive performance. Reprod Domest Anim 42 (Suppl 2): 17-23.
Dobson H, Walker SL, Morris MJ, Routly JE, Smith RF (2008) Why is it getting more difficult to successfully artificially inseminate dairy cows? Animal 2: 1104-1111.
Dymnicki E, Krzyżewski J, Oprządek J, Reklewski Z, Oprządek A (2003) Relationship between the length of calving intervals and milk trace in black-and-white cows. Med Weter 9: 792-796.
Januś E, Borkowska D (2012) Correlations between milk yield in primiparous PHF cows and selected lifetime performance and fertility indi-cators as well as reasons for culling, Acta Sci Pol Zootech 11: 23-32.
Lopez H, Satter LD, Wiltbank MC (2004) Relationship between level of milk production and estrous behavior of lactating dairy cows. Anim Reprod Sci 81: 209-223.
Lucy MC (2007) Fertility in high-producing dairy cows: reasons for decline and corrective strategies for sustainable improvement. Soc Reprod Fertil Suppl. 64: 237-254.
Mee JF (2007) The role of the veterinarian in bovine fertility management on modern dairy farms. Theriogenology 68 (Suppl 1): 257-265.
Mee JF (2010) Veterinary dairy herd fertility service provision in seasonal and non-seasonal dairy industries – a comparison. Ir Vet J 63: 230-235.
Morek-Kopeć M, Żarnecki A (2009) Culling reasons in the population of Polish Holstein-Friesian Black and White cows. Rocz Nauk PTZ 5: 9-17.
Noordhuizen JP, Wentink GH (2001) Developments in veterinary herd health programmes on dairy farms: a review. Vet Q 23: 162-169.
Norman HD, Wright JR, Hubbard SM, Miller RH, Hutchison JL (2009) Reproductive status of Holstein and Jersey cows in the United States. J Dairy Sci 92: 3517-3528.
Polska Federacja Hodowców Bydła i Producentów Mleka (PFHBiPM) (2020) Evaluation and breeding of dairy cattle. Dane za rok 2019. pfhb.pl PFHBiPM Wyniki poglad 2020 WEB.
Roche JF (2006) The effect of nutritional management of the dairy cow on reproductive efficiency. Anim Reprod Sci 96: 282-296.
Royal M, Mann GE, Flint AP (2000) Strategies for reversing the trend towards subfertility in dairy cattle. Vet J 160: 53-60.
Sangsritavong S, Combs DK, Sartori R, Armentano LE, Wiltbank MC (2002) High feed intake increases liver blood flow and metabolism of progesterone and estra- diol-17beta in dairy cattle. J Dairy Sci 85: 2831-2842.
Walsh SW, Williams EJ, Evans AC (2011) A review of the causes of poor fertility in high milk producing dairy cows. Anim Reprod Sci 123: 127-138.
Wiltbank M, Lopez H, Sartori R, Sangsritavong S, Gümen A (2006) Changes in reproductive physiology of lactating dairy cows due to ele-vated steroid metabolism. Therio- genology 65: 17-29.
Zduńczyk S, Janowski T, Raś M (2005) Current views on the phenomenon of silent heat in cows. Med Weter 61: 726-729.

Barański W, Nowicki A, Zduńczyk S, Janowski T (2018) Incidence of clinical form of anestrus after unsuccessful service in cows in eight dairy herds in north-east of Poland. Pol J Vet Sci 21: 377-381.
Barański W, Zduńczyk S, Janowski T (2012) Late embryonic and foetal losses in eight dairy herds in north-east Poland. Pol J Vet Sci 15: 735-739.
Bartlett PC, Kirk J, Coe P, Marteniuk J, Mather EC (1987) Descriptive epidemiology of anestrus in Michigan Holstein-Friesian cattle. Theriogenology 27: 459-476.
Baryczka A, Barański W, Nowicki A, Zduńczyk S, Janowski T (2018) Effect of single treatment with cloprostenol or dinoprost on estrus and reproductive performance in anestrous dairy cows after service. Pol J Vet Sci 21: 383-387.
Dobson H, Walker SL, Morris MJ, Routly JE, Smith RF (2008) Why is it getting more difficult to successfully artificially inseminate dairy cows? Animal 2: 1104-1111.
Forar AL, Gay JM, Hancock DD, Gay CC (1996) Fetal loss frequency in ten Holstein dairy herds. Theriogenology 45: 1505-1513.
Lopez H, Satter LD, Wiltbank MC (2004) Relationship between level of milk production and estrous behavior of lactating dairy cows. Anim Reprod Sci 81: 209-223.
Lucy MC (2001) Reproductive loss in high-producing dairy cattle: where will it end? J Dairy Sci 84: 1277-1293.
Martinez J, Thibier M (1984) Reproductive disorders in dairy cattle: I. Respective influence of herds, seasons, milk yield and parity. Theri-ogenology 21: 569-581.
Mateus L, da Costa LL, Cardos JJ, Silva JR (2002) Treatment of unobserved oestrus in a dairy cattle herd with low oestrous detection rate up to 60 days post-partum. Reprod Domest Anim 37: 57-60.
McDougall S (2010) Effects of treatment of anestrous dairy cows with gonadotropin-releasing hormone, prostaglandin, and progesterone. J Dairy Sci 93: 1944-1959.
Mwaanga ES, Janowski T, Zduńczyk S (1999) Incidence of silent heat in cows and the effectiveness of its diagnosis and treatment with PGF2 alpha analogue, cloprostenol. Pol J Vet Sci 2: 109-112.
Nation DP, Morton J, Cavalieri J, MacMillan KL (2001) Factors associated with the incidence of ‘Phantom cows’ in Australian dairy herds. Proc N Z Soc Anim Prod 61: 180-183.
Nowicki A, Barański W, Baryczka A, Janowski T (2017) OvSynch Protocol and its Modifications in the Reproduction Management of Dairy Cattle Herds - an Update. J Vet Res 61: 329-336.
Paisley LG, Mickelsen WD, Frost OL (1978) A survey of the incidence of prenatal mortality in cattle following pregnancy diagnosis by rectal palpation. Theriogenology 9: 481-491.
Pilawski W, Siemieniuch MJ, Skarżyński DJ (2008) Influence of estrus synchronization and superovulation on corpus luteum functioning in cattle. Does hormonal manipulation always provide desirable effects? Med Weter 64: 525-527.
Plunkett SS, Stevenson JS, Call EP (1984) Prostaglandin F2 alpha for lactating dairy cows with a palpable corpus luteum but unobserved estrus. J Dairy Sci 67: 380-387.
Pursley JR, Mee MO, Wiltbank MC (1995) Synchronization of ovulation in dairy cows using PGF2alpha and GnRH. Theriogenology 44: 915-923.
Rabiee AR, Lean IJ, Stevenson MA (2005) Efficacy of Ovsynch program on reproductive performance in dairy cattle: a meta-analysis. J Dairy Sci 88: 2754-2770.
Répási A, Beckers JF, Sulon J, Karen A, Reiczigel J, Szenci O (2005) Effect of the type and number of prostaglandin treatments on corpus luteum, the largest follicle and progesterone concentration in dairy cows. Reprod Domest Anim 40: 436-442.
Rhodes FM, McDougall S, Burke CR, Verkerk GA, Macmillan KL (2003) Invited review: Treatment of cows with an extended postpartum anestrous interval. J Dairy Sci 86: 1876-1894.
Seguin B, Momont H, Baumann L (1985) C1oprostenol and dinoprost tromethamine in experimental and field trials treating unobserved estrus in dairy cows. Bovine Pract 20: 85-90.
Skarżynski DJ, Siemieniuch MJ, Pilawski W, Wocławek Potocka I, Bah MM, Majewska M, Jaroszewski JJ (2008) In vitro assessment of progesterone and prostaglandin E2 production by the corpus luteum in cattle following pharmacological synchronization of estrus. J Reprod Dev 55: 170-176.
Stevenson JS, Pursley JR (1994) Use of milk progesterone and prostaglandin F2 alpha in a scheduled artificial insemination program. J Dairy Sci 77: 1755-1760.
Szenci O, Beckers JF, Humblot P, Sulon J, Sasser G, Taverne MA, Varga J, Baltusen R, Schekk G (1998) Comparison of ultrasonography, bovine pregnancy-specific protein B, and bovine pregnancy-associated glycoprotein 1 test for pregnancy detection in dairy cows. Theriogeno- logy 50: 77-88.

1. Al Smadi MA, Hammadeh ME, Batiha O, Al Sharu E, Altalib MM, Jahmani MY, Mahdy A, Amor H (2021) Elevated seminal protein carbonyl concentration is correlated with asthenozoospermia and affects adversely the laboratory intracytoplasmic sperm injection (ICSI) outcomes. Andrologia 53: e14232.
2. Angrimani DS, Brito MM, Rui BR, Nichi M, Vannucchi CI (2020) Reproductive and endocrinological effects of Benign Prostatic Hy-perplasia and finasteride therapy in dogs. Sci Rep 10: 14834.
3. Aquino-Cortez A, Pinheiro BQ, Lima DB, Silva HV, Mota-Filho AC, Martins JA, Rodriguez-Villamil P, Moura AA, Silva LD (2017) Proteomic characterization of canine seminal plasma. Theriogenology 95: 178-186.
4. Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O, Erten K, Ozgok Y, Dimovski A (2006) Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem 39: 176-179.
5. Barsanti JA, Finco DR (1986) Canine prostatic diseases. Vet Clin North Am Small Anim Pract 16: 587-599.
6. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of „antioxidant power”: The FRAP assay. Anal Biochem 239: 70-76.
7. Bergsma AT, Li HT, Eliveld J, Bulthuis ML, Hoek A, van Goor H, Bourgonje AR, Cantineau AE (2022) Local and systemic oxidative stress biomarkers for male infertility: The ORION study. Antioxidants (Basel) 11: 1045.
8. Berry SJ, Strandberg JD, Saunders WJ, Coffey DS (1986) Development of canine benign prostatic hyperplasia with age. Prostate 9: 363-373.
9. Castleton PE, Deluao JC, Sharkey DJ, McPherson NO (2022) Measuring reactive oxygen species in semen for male preconception care: A scientist perspective. Antioxidants (Basel) 11: 264.
10. Cunto M, Ballotta G, Zambelli D (2022) Benign prostatic hyperplasia in the dog. Anim Reprod Sci 247: 107096.
11. Da Rocha AA, da Cunha ICN, Ederli BB, Albernaz AP, Quirino CR (2009) Effect of daily food supplementation with essential fatty ac-ids on canine semen quality. Reprod Dom Anim 44, (Suppl 2): 313-315.
12. Dearakhshandeh N, Mogheiseh A, Nazifi S, Ahrari Khafi MS, Abbaszadeh Hasiri M, Golchin-Rad K (2019) Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH-induced dogs with an anti-proliferative agent called tadalafil. J Vet Pharmacol Ther 42: 665-672.
13. De Souza FF, Barreto CS, Lopes MD (2007) Characteristics of seminal plasma proteins and their correlation with canine semen analysis. Theriogenology 68: 100-106.
14. Domosławska A, Zdunczyk S (2020) Clinical and spermatological findings in male dogs with acquired infertility: A retrospective analy-sis. Andrologia 52: e13802.
15. Domoslawska A, Zdunczyk S, Franczyk M, Kankofer M, Janowski T (2018) Selenium and vitamin E supplementation enhances the an-tioxidant status of spermatozoa and improves semen quality in male dogs with lowered fertility. Andrologia 50: e13023
16. Domosławska A, Zdunczyk S, Franczyk M, Kankofer M, Janowski T (2019) Total antioxidant capacity and protein peroxidation inten-sity in seminal plasma of infertile and fertile dogs. Reprod Domest Anim 54: 252-257.
17. Domosławska A, Zduńczyk S, Kankofer M, Bielecka A (2022) Oxidative stress biomarkers in dogs with benign prostatic hyperplasia. Ir Vet J 75: 21.
18. Ferré-Dolcet L, Frigotto L, Contiero B, Bedin S, Romagnoli S (2022) Prostatic fluid composition and semen quality in dogs with benign prostatic hyperplasia undergoing treatment with osaterone acetate. Reprod Domest Anim 57: 72-79.
19. Fontbonne A (2011) Infertility in male dogs: recent advances. Rev Bras Reprod Anim 35: 266-273.
20. Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, Sciarra A, Montorsi F (2013) The role of chronic prostatic in-flammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int 112: 432-441.
21. Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experi-mental data. Free Radic Biol Med 29: 1106-1114.
22. Gobello C, Corrada Y (2002) Noninfectious prostatic diseases in dogs. Compend Contin Educ Pract Vet 24: 99-107.
23. Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142: 231-255.
24. Kankofer M (2001) Protein peroxidation processes in bovine retained and not-retained placenta. J Vet Med A Physiol Pathol Clin Med 48: 207-2212.
25. Kawakami E, Kobayashi M, Hori T, Kaneda T (2015) Therapeutic effects of vitamin E in 4 dogs with poor semen quality and low su-peroxide dismutase activity in seminal plasma. J Vet Med Sci 77: 1711-1714.
26. Lévy X, Niżański W, von Heimendahl A, Mimouni P (2014) Diagnosis of common prostatic conditions in dogs: an update. Reprod Domest Anim 49 (Suppl 2): 50-57.
27. Linde-Forsberg C (1991) Achieving canine pregnancy by using frozen or chilled extended semen. Vet Clin North Am Small Anim Pract 21: 467-485.
28. Meikle AW, Collier ES, Stringham JD, Fang SM, Taylor GN (1981) Elevated intranuclear dihydrotestosterone in prostatic hyperplasia of aging dogs. J Steroid Biochem 14: 331-335.
29. Memon MA (2007) Common causes of male dog infertility. Theriogenology 68: 322-328.
30. Minciullo PL, Inferrera A, Navarra M, Calapai G, Magno C, Gangemi S (2015) Oxidative stress in benign prostatic hyperplasia: a sys-tematic review. Urol Int 94: 249-254.
31. Mitsunari K, Miyata Y, Matsuo T, Mukae Y, Otsubo A, Harada J, Kondo T, Matsuda T, Ohba K, Sakai H (2021) Pharmacological Ef-fects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia. Molecules 26: 450.
32. Morielli T, O’Flaherty C (2015) Oxidative stress impairs function and increases redox protein modifications in human spermatozoa. Re-production 149: 113-23.
33. Nowicka-Bauer K, Lepczynski A, Ozgo M, Kamieniczna M, Fraczek M, Stanski L, Olszewska M, Malcher A, Skrzypczak W, Kurpisz MK (2018) Sperm mitochondrial dysfunction and oxidative stress as possible reasons for isolated asthenozoospermia. J Physiol Phar-macol 69.
34. Pace G, Di Massimo C, De Amicis D, Corbacelli C, Di Renzo L, Vicentini C, Miano L, Tozzi Ciancarelli MG (2010) Oxidative stress in benign prostatic hyperplasia and prostate cancer. Urol Int 85: 328-333.
35. Rice- Evans CA, Diplock AT, Symons MCR (1991) Techniques in Free Radical Research, 1st ed., Elsevier, Amsterdam.
36. Roumeguère T, Sfeir J, El Rassy E, Albisinni S, Van Antwerpen P, Boudjeltia KZ, Farès N, Kattan J, Aoun F (2017) Oxidative stress and prostatic diseases. Mol Clin Oncol 7: 723-728.
37. Schäfer-Somi S (2023) Diseases of the Canine Prostate Gland. IntechOpen. Doi: 10.5772/intechopen.105835.
38. Smith J (2008) Canine prostatic disease: a review of anatomy, pathology, diagnosis, and treatment. Theriogenology 70: 375-383.
39. Srivastava DS, Mittal RD (2005) Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate can-cer. Indian J Clin Biochem 20: 162-165.
40. Stadtman ER, Levine RL (2000) Protein oxidation. Ann N Y Acad Sci 899: 191-208.
41. Stewart KL, Lephart ED (2023) Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome. Int J Mol Sci 24: 5486.
42. Strzeżek R, Koziorowska-Gilun M, Kowalówka M, Strzeżek J (2009) Characteristics of antioxidant system in dog semen. Pol J Vet Sci 12: 55-60.
43. Tong Y, Zhou RY (2020) Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia. Mediators Inflamm 2020: 7958316.
44. Tunn S, Hochstrate H, Habenicht UF, Krieg M (1988) 5 alpha-reductase activity in epithelium and stroma of prostates from intact and castrated dogs treated with androstenedione, the aromatase inhibitor 1-methyl-1,4androstadiene-3,17-dione, and cyproterone acetate. Prostate 12: 243-253.
45. Vital P, Castro P, Ittmann M (2016) Oxidative stress promotes benign prostatic hyperplasia. Prostate 76: 58-67.
46. Worobiej E, Klepacka M (2003) Degradation changes induced by hydroxyl radicals in bean (Phaseolus vulgaris) and pea (Pisum sa-tivum) proteins. Pol J Food Nutr Sci 53: 13-17.

1. Agarwal A, Virk G, Ong C, du Plessis SS (2014) Effect of oxidative stress on male reproduction. World J Mens Health 32: 1-17.
2. Angrimani DS, Brito MM, Rui BR, Nichi M, Vannucchi CI (2020) Reproductive and endocrinological effects of Benign Prostatic Hy-perplasia and finasteride therapy in dogs. Sci Rep 10: 14834.
3. Aquino-Cortez A, Pinheiro BQ, Lima DB, Silva HV, Mota-Filho AC, Martins JAM Rodriguez-Villamil P, Moura AA, Silva LD (2017) Proteomic characterization of canine seminal plasma. Theriogenology 95: 178-186.
4. Balercia G, Moretti S, Vignini A, Magagnini M, Mantero F, Boscaro M, Ricciardo-Lamonica G, Mazzanti L (2004) Role of nitric oxide concentrations on human sperm motility. J Androl 25: 245-249.
5. Berry SJ, Strandberg JD, Saunders WJ, Coffey DS (1986) Development of canine benign prostatic hyperplasia with age. Prostate 9: 363-73.
6. Carson C 3rd, Rittmaster R (2003) The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 61 (4 Suppl 1): 2-7.
7. Cochran RC, Ewing LL, Niswender GD (1981) Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testos-terone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 be-ta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia. Invest Urol 19: 142-147.
8. Cunto M, Ballotta G, Zambelli D (2022) Benign prostatic hyperplasia in the dog. Anim Reprod Sci 247: 107096.
9. Dearakhshandeh N, Mogheiseh A, Nazifi S, Ahrari Khafi MS, Abbaszadeh Hasiri M, Golchin-Rad K (2019) Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH induced dogs with an anti-proliferative agent called tadalafil. J Vet Pharmacol Ther 42: 665–672.
10. Domosławska A, Zduńczyk S, Kankofer M, Bielecka A (2022) Oxidative stress biomarkers in dogs with benign prostatic hyperplasia. Ir Vet J 75: 21.
11. Domosławska A, Zduńczyk S, Niżański W, Janowski T (2013) Assessment of semen quality in infertile dogs using computer-assisted sperm analysis by the Hamilton-Thorne Semen Analyser. Bull Vet Inst Pulawy 57: 429-432.
12. Doshi SB, Khullar K, Sharma RK, Agarwal A (2012) Role of reactive nitrogen species in male infertility. Reprod Biol Endocrinol 10: 109.
13. Fafula RV, Iefremova UP, Onufrovych OK, Maksymyuk HV, Besedina AS, Nakonechnyi IA, Vorobets DZ, Vorobets ZD (2018) Al-terations in Arginase-NO-synthase System of Spermatozoa in Human Subjects with Different Fertility Potential. J Med Biochem 37: 134-140.
14. Ferré-Dolcet L, Frigotto L, Contiero B, Bedin S, Romagnoli S (2022) Prostatic fluid composition and semen quality in dogs with benign prostatic hyperplasia undergoing treatment with osaterone acetate. Reprod Domest Anim 57: 72-79.
15. Flores RB, Angrimani D, Rui BR, Brito MM, Abreu RA, Vannucchi CI (2017) The influence of benign prostatic hyperplasia on sperm morphological features and sperm DNA integrity in dogs. Repro Domest Anim 52 (Suppl 2): 310-315.
16. Fontbonne A (2011) Infertility in male dogs: recent advances. Rev Bras Reprod Anim 35: 266-273.
17. Fraser L, Lecewicz M, Strzeżek J (2002) Fluorometric assessments of viability and mitochondrial status of boar spermatozoa following liquid storage. Pol J Vet Sci 5: 85-92.
18. Garner DL, Johnson LA (1995) Viability assessment of mammalian sperm using SYBR-14 and propidium iodide. Biol Reprod 53: 276–284.
19. Herrero MB, Pérez Martínez S, Viggiano JM, Polak JM, de Gimeno MF (1996) Localization by indirect immunofluorescence of nitric oxide synthase in mouse and human spermatozoa. Reprod Fertil Dev 8:931-934.
20. Krakowski L, Wąchocka A, Brodzki P, Wrona Z, Piech T, Wawron W, Chałabis-Mazurek A (2015) Sperm quality and selected bio-chemical parameters of seminal fluid in dogs with benign prostatic hyperplasia. Anim Reprod Sci 160: 20-125.
21. Lampiao F, Huussen J, du Plessis SS (2014) Effects of nitric oxide exposure on human sperm function and apoptosis markers. Open Reprod Sci J 6: 17-20.
22. Lampiao F, Strijdom H, du Plessis SS (2006) Direct nitric oxide measurement in human spermatozoa: flow cytometric analysis using the fluorescent probe, diaminofluorescein. Int J Androl 29:564-567. DOI: 10.1111/j.1365-2605.2006. 00695.x.
23. Lévy X, Niżański W, von Heimendahl A, Mimouni P (2014) Diagnosis of common prostatic conditions in dogs: an update. Reprod Domest Anim 49 (Suppl 2): 50-57.
24. Linde-Forsberg C (1991) Achieving canine pregnancy by using frozen or chilled extended semen. Vet Clin North Am Small Anim Pract 21: 467-485.
25. Luo Y, Zhu Y, Basang W, Wang X, Li C, Zhou X (2021) Roles of Nitric Oxide in the Regulation of Reproduction: A Review. Front Endocrinol (Lausanne) 12: 52410.
26. Minciullo PL, Inferrera A, Navarra M, Calapai G, Magno C, Gangemi S (2015) Oxidative stress in benign prostatic hyperplasia: a sys-tematic review. Urol Int 94: 249-254.
27. Niżański W, Eberhardt M, Ochota M, Fontaine C, Levy X, Pasikowska J (2022) A Comparative Study of the Effects of Osaterone Ace-tate and Deslorelin Acetate on Sperm Kinematics and Morpho-Functional Parameters in Dogs. Animals (Basel) 12: 1548.
28. Orzołek A, Zasiadczyk Ł, Wysocki P, Kordan W, Krysztofiak P (2018) Relation between nitric oxide (NO) level in semen and certain properties of boar spermatozoa stored at 17°C. Pol J Vet Sci 21: 423-426.
29. Paoli D, Gallo M, Rizzo F, Baldi E, Francavilla S, Lenzi A, Lombardo F, Gandini L (2011) Mitochondrial membrane potential profile and its correlation with increasing sperm motility. Fertil Steril 95: 2315-2319.
30. Polisca A, Troisi A, Fontaine E, Menchetti L, Fontbonne A (2016) A retrospective study of canine prostatic diseases from 2002 to 2009 at the Alfort Veterinary College in France. Theriogenology 85: 835-840.
31. Ramaswamy S, Weinbauer GF (2015) Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone. Spermatogenesis 4: e996025.
32. Rijsselaere T, Van Soom A, Maes D, Verberckmoes S, de Kruif A (2004) Effect of blood admixture on in vitro survival of chilled and frozen-thawed canine spermatozoa. Theriogenology 61: 1589-1602.
33. Rosselli M, Dubey RK, Imthurn B, Macas E, Keller PJ (1995) Effects of nitric oxide on human spermatozoa: evidence that nitric oxide decreases sperm motility and induces sperm toxicity. Hum Reprod 10: 1786-1790.
34. Ruel Y, Barthez PY, Mailles A, Begon D (1998) Ultrasonographic evaluation of the prostate in healthy intact dogs. Vet Radiol Ultra-sound 39: 212-6.
35. Smith J (2008) Canine prostatic disease: a review of anatomy, pathology, diagnosis, and treatment. Theriogenology 70: 375-383.
36. Strzeżek R, Szemplińska K, Filipowicz K, Kordan W (2015) Semen characteristics and selected biochemical markers of canine seminal plasma in various seasons of the year. Pol J Vet Sci 18: 13-18.
37. Thomas CA, Garner DL, DeJarnette JM, Marshall CE (1998) Effect of cryopreservation of bovine sperm organelle function and viability as determined by flow cytometry. Biol Reprod 58: 786-793.
38. Tong Y, Zhou RY (2020) Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia. Mediators Inflamm 2020: 7958316.
39. Trzcińska M, Bryła M (2015) Apoptotic-like changes of boar spermatozoa in freezing media supplemented with different antioxidants. Pol J Vet Sci 18: 473-480.
40. Uribe P, Boguen R, Treulen F, Sánchez R, Villegas JV (2015) Peroxynitrite-mediated nitrosative stress decreases motility and mitochon-drial membrane potential in human spermatozoa. Mol Hum Reprod 21: 237-243.
41. Vital P, Castro P, Ittmann M (2016) Oxidative stress promotes benign prostatic hyperplasia. Prostate 76: 58-67.
42. Volpe S, Leoci R, Aiudi G, Lacalandra GM (2009) Relationship between motility and mitochondrial functional status in canine sperma-tozoa. Reprod Domest Anim 44 (Suppl 2): 275-278.